HEADER VIRAL PROTEIN 23-APR-24 9F2H TITLE CRYSTAL STRUCTURE OF SARS-COV-2 N-PROTEIN C-TERMINAL DOMAIN IN COMPLEX TITLE 2 WITH RILUZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEOPROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: N,NUCLEOCAPSID PROTEIN,NC,PROTEIN N; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: C-TERMINAL DOMAIN. INITIAL GS ARE EXPRESSION TAGS. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PET; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28-TXAHEV KEYWDS CTD, SARS-COV-2 NUCLEOCAPSID, COVID-19, RILUZOLE, BENZOTHIAZOLS, KEYWDS 2 VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.A.MARQUEZ-MONINO,B.GONZALEZ,J.M.PEREZ-CANADILLAS REVDAT 3 15-JAN-25 9F2H 1 JRNL REVDAT 2 27-NOV-24 9F2H 1 JRNL REVDAT 1 13-NOV-24 9F2H 0 JRNL AUTH M.A.MARQUEZ-MONINO,C.M.SANTIVERI,P.DE LEON,S.CAMERO, JRNL AUTH 2 R.CAMPOS-OLIVAS,M.A.JIMENEZ,M.SAIZ,B.GONZALEZ, JRNL AUTH 3 J.M.PEREZ-CANADILLAS JRNL TITL THE ALS DRUG RILUZOLE BINDS TO THE C-TERMINAL DOMAIN OF JRNL TITL 2 SARS-COV-2 NUCLEOCAPSID PROTEIN AND HAS ANTIVIRAL ACTIVITY. JRNL REF STRUCTURE V. 33 39 2025 JRNL REFN ISSN 0969-2126 JRNL PMID 39541975 JRNL DOI 10.1016/J.STR.2024.10.025 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0411 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 98450 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5140 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.33 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6822 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.2560 REMARK 3 BIN FREE R VALUE SET COUNT : 344 REMARK 3 BIN FREE R VALUE : 0.2500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3488 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 626 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.43 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.29000 REMARK 3 B22 (A**2) : -0.23000 REMARK 3 B33 (A**2) : -0.08000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.38000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.052 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.053 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.036 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.851 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.975 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.966 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3841 ; 0.006 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 3573 ; 0.001 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5220 ; 1.360 ; 1.669 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8243 ; 0.478 ; 1.586 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 476 ; 6.531 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 31 ; 7.485 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 659 ;14.081 ;10.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 526 ; 0.074 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4737 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 983 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1850 ; 1.296 ; 1.675 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1850 ; 1.295 ; 1.675 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2344 ; 2.066 ; 2.997 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2345 ; 2.066 ; 2.997 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1991 ; 1.922 ; 1.989 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1992 ; 1.922 ; 1.990 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2877 ; 3.069 ; 3.522 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4761 ; 4.711 ;21.660 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4519 ; 4.384 ;18.440 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 9F2H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-APR-24. REMARK 100 THE DEPOSITION ID IS D_1292131922. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.774899 REMARK 200 MONOCHROMATOR : CHANNEL-CUT SI(111) REMARK 200 OPTICS : TOROIDAL MIRROR, ELLIPTICAL BEAM REMARK 200 SHAPE REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X CDTE 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 103602 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 46.560 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: RODS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350 38%, 0.1 M TRIS PH 8.5, 50 MM REMARK 280 AMMONIUM SULFATE AND 1 MM INSP6. PROTEIN:PRECIPITANT RATIO 1:1. REMARK 280 PROTEIN CONCENTRATION: 16.5 MG/ML. PROTEIN BUFFER: 20 MM TRIS PH REMARK 280 8.0 AND 150 MM NACL. SOAKING O/N WITH SATURATED CONCENTRATION OF REMARK 280 RILUZOLE IN PEG 3350 40%, 0.1 M TRIS PH 8.5, 50 MM AMMONIUM REMARK 280 SULFATE, 1 MM INSP6 CONDITION., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z+1/2 REMARK 290 4555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 45.15431 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.69150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 54.64574 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 45.15431 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 21.69150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 54.64574 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -42.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5530 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 254 REMARK 465 SER A 255 REMARK 465 LYS A 256 REMARK 465 GLY B 254 REMARK 465 GLY C 254 REMARK 465 SER C 255 REMARK 465 GLY D 254 REMARK 465 SER D 255 REMARK 465 LYS D 256 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS B 256 -58.49 69.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 259 0.14 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 9F2G RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT INHIBITOR. DBREF 9F2H A 256 364 UNP P0DTC9 NCAP_SARS2 256 364 DBREF 9F2H B 256 364 UNP P0DTC9 NCAP_SARS2 256 364 DBREF 9F2H C 256 364 UNP P0DTC9 NCAP_SARS2 256 364 DBREF 9F2H D 256 364 UNP P0DTC9 NCAP_SARS2 256 364 SEQADV 9F2H GLY A 254 UNP P0DTC9 EXPRESSION TAG SEQADV 9F2H SER A 255 UNP P0DTC9 EXPRESSION TAG SEQADV 9F2H GLY B 254 UNP P0DTC9 EXPRESSION TAG SEQADV 9F2H SER B 255 UNP P0DTC9 EXPRESSION TAG SEQADV 9F2H GLY C 254 UNP P0DTC9 EXPRESSION TAG SEQADV 9F2H SER C 255 UNP P0DTC9 EXPRESSION TAG SEQADV 9F2H GLY D 254 UNP P0DTC9 EXPRESSION TAG SEQADV 9F2H SER D 255 UNP P0DTC9 EXPRESSION TAG SEQRES 1 A 111 GLY SER LYS LYS PRO ARG GLN LYS ARG THR ALA THR LYS SEQRES 2 A 111 ALA TYR ASN VAL THR GLN ALA PHE GLY ARG ARG GLY PRO SEQRES 3 A 111 GLU GLN THR GLN GLY ASN PHE GLY ASP GLN GLU LEU ILE SEQRES 4 A 111 ARG GLN GLY THR ASP TYR LYS HIS TRP PRO GLN ILE ALA SEQRES 5 A 111 GLN PHE ALA PRO SER ALA SER ALA PHE PHE GLY MET SER SEQRES 6 A 111 ARG ILE GLY MET GLU VAL THR PRO SER GLY THR TRP LEU SEQRES 7 A 111 THR TYR THR GLY ALA ILE LYS LEU ASP ASP LYS ASP PRO SEQRES 8 A 111 ASN PHE LYS ASP GLN VAL ILE LEU LEU ASN LYS HIS ILE SEQRES 9 A 111 ASP ALA TYR LYS THR PHE PRO SEQRES 1 B 111 GLY SER LYS LYS PRO ARG GLN LYS ARG THR ALA THR LYS SEQRES 2 B 111 ALA TYR ASN VAL THR GLN ALA PHE GLY ARG ARG GLY PRO SEQRES 3 B 111 GLU GLN THR GLN GLY ASN PHE GLY ASP GLN GLU LEU ILE SEQRES 4 B 111 ARG GLN GLY THR ASP TYR LYS HIS TRP PRO GLN ILE ALA SEQRES 5 B 111 GLN PHE ALA PRO SER ALA SER ALA PHE PHE GLY MET SER SEQRES 6 B 111 ARG ILE GLY MET GLU VAL THR PRO SER GLY THR TRP LEU SEQRES 7 B 111 THR TYR THR GLY ALA ILE LYS LEU ASP ASP LYS ASP PRO SEQRES 8 B 111 ASN PHE LYS ASP GLN VAL ILE LEU LEU ASN LYS HIS ILE SEQRES 9 B 111 ASP ALA TYR LYS THR PHE PRO SEQRES 1 C 111 GLY SER LYS LYS PRO ARG GLN LYS ARG THR ALA THR LYS SEQRES 2 C 111 ALA TYR ASN VAL THR GLN ALA PHE GLY ARG ARG GLY PRO SEQRES 3 C 111 GLU GLN THR GLN GLY ASN PHE GLY ASP GLN GLU LEU ILE SEQRES 4 C 111 ARG GLN GLY THR ASP TYR LYS HIS TRP PRO GLN ILE ALA SEQRES 5 C 111 GLN PHE ALA PRO SER ALA SER ALA PHE PHE GLY MET SER SEQRES 6 C 111 ARG ILE GLY MET GLU VAL THR PRO SER GLY THR TRP LEU SEQRES 7 C 111 THR TYR THR GLY ALA ILE LYS LEU ASP ASP LYS ASP PRO SEQRES 8 C 111 ASN PHE LYS ASP GLN VAL ILE LEU LEU ASN LYS HIS ILE SEQRES 9 C 111 ASP ALA TYR LYS THR PHE PRO SEQRES 1 D 111 GLY SER LYS LYS PRO ARG GLN LYS ARG THR ALA THR LYS SEQRES 2 D 111 ALA TYR ASN VAL THR GLN ALA PHE GLY ARG ARG GLY PRO SEQRES 3 D 111 GLU GLN THR GLN GLY ASN PHE GLY ASP GLN GLU LEU ILE SEQRES 4 D 111 ARG GLN GLY THR ASP TYR LYS HIS TRP PRO GLN ILE ALA SEQRES 5 D 111 GLN PHE ALA PRO SER ALA SER ALA PHE PHE GLY MET SER SEQRES 6 D 111 ARG ILE GLY MET GLU VAL THR PRO SER GLY THR TRP LEU SEQRES 7 D 111 THR TYR THR GLY ALA ILE LYS LEU ASP ASP LYS ASP PRO SEQRES 8 D 111 ASN PHE LYS ASP GLN VAL ILE LEU LEU ASN LYS HIS ILE SEQRES 9 D 111 ASP ALA TYR LYS THR PHE PRO HET 657 A 401 15 HET SO4 A 402 5 HET SO4 B 401 5 HET EDO C 401 4 HET SO4 D 401 5 HETNAM 657 6-(TRIFLUOROMETHOXY)-1,3-BENZOTHIAZOL-2-AMINE HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN 657 RILUZOLE HETSYN EDO ETHYLENE GLYCOL FORMUL 5 657 C8 H5 F3 N2 O S FORMUL 6 SO4 3(O4 S 2-) FORMUL 8 EDO C2 H6 O2 FORMUL 10 HOH *626(H2 O) HELIX 1 AA1 PRO A 258 ARG A 262 5 5 HELIX 2 AA2 ASN A 269 GLY A 275 1 7 HELIX 3 AA3 ASP A 288 GLY A 295 1 8 HELIX 4 AA4 THR A 296 TYR A 298 5 3 HELIX 5 AA5 HIS A 300 GLN A 306 1 7 HELIX 6 AA6 SER A 310 SER A 318 1 9 HELIX 7 AA7 ASN A 345 ILE A 357 1 13 HELIX 8 AA8 ASP A 358 PHE A 363 5 6 HELIX 9 AA9 PRO B 258 ARG B 262 5 5 HELIX 10 AB1 ASN B 269 GLY B 275 1 7 HELIX 11 AB2 ASP B 288 GLY B 295 1 8 HELIX 12 AB3 THR B 296 TYR B 298 5 3 HELIX 13 AB4 HIS B 300 GLN B 306 1 7 HELIX 14 AB5 SER B 310 SER B 318 1 9 HELIX 15 AB6 ASN B 345 ILE B 357 1 13 HELIX 16 AB7 ASP B 358 PHE B 363 5 6 HELIX 17 AB8 PRO C 258 ARG C 262 5 5 HELIX 18 AB9 ASN C 269 GLY C 275 1 7 HELIX 19 AC1 ASP C 288 GLY C 295 1 8 HELIX 20 AC2 THR C 296 TYR C 298 5 3 HELIX 21 AC3 HIS C 300 GLN C 306 1 7 HELIX 22 AC4 SER C 310 SER C 318 1 9 HELIX 23 AC5 ASN C 345 ILE C 357 1 13 HELIX 24 AC6 ASP C 358 PHE C 363 5 6 HELIX 25 AC7 PRO D 258 ARG D 262 5 5 HELIX 26 AC8 ASN D 269 GLY D 275 1 7 HELIX 27 AC9 ASP D 288 GLY D 295 1 8 HELIX 28 AD1 THR D 296 TYR D 298 5 3 HELIX 29 AD2 HIS D 300 GLN D 306 1 7 HELIX 30 AD3 SER D 310 SER D 318 1 9 HELIX 31 AD4 ASN D 345 ILE D 357 1 13 HELIX 32 AD5 ASP D 358 PHE D 363 5 6 SHEET 1 AA1 4 ARG A 319 THR A 325 0 SHEET 2 AA1 4 GLY A 328 LYS A 338 -1 O THR A 334 N ARG A 319 SHEET 3 AA1 4 GLY B 328 LYS B 338 -1 O LEU B 331 N ILE A 337 SHEET 4 AA1 4 ARG B 319 THR B 325 -1 N ARG B 319 O THR B 334 SHEET 1 AA2 4 ARG C 319 THR C 325 0 SHEET 2 AA2 4 GLY C 328 LYS C 338 -1 O TRP C 330 N GLU C 323 SHEET 3 AA2 4 GLY D 328 LYS D 338 -1 O LEU D 331 N ILE C 337 SHEET 4 AA2 4 ARG D 319 THR D 325 -1 N ARG D 319 O THR D 334 CRYST1 93.056 43.383 109.326 90.00 91.44 90.00 I 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010746 0.000000 0.000271 0.00000 SCALE2 0.000000 0.023051 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009150 0.00000